Mucoadhesive Nanoparticles for Drug Delivery to the Anterior Eye
While the use of topical drops for the delivery of drugs to the anterior of the eye is well accepted, it is far from efficient with as little as 5% of the drug instilled on the eye actually reaching the target tissue. The ability to prolong the residence time on the eye is desirable. Based on the ac...
Main Authors: | Nicole Mangiacotte, Graeme Prosperi-Porta, Lina Liu, Megan Dodd, Heather Sheardown |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | Nanomaterials |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-4991/10/7/1400 |
Similar Items
-
Novel approaches for posterior segment ocular drug delivery with folate-modified liposomal formulation
by: Toshiki Hayashi, et al.
Published: (2016-02-01) -
Effect of the buffer system on stability of tetracaine hydrochloride 0.5% eyedrops
by: Emilija Fredro-Kumbaradzi, et al.
Published: (2002-04-01) -
Noncompliance with drug therapy of glaucoma: a review about intervening factors
by: Aldemar Nemésio Brandão Vilela de Castro, et al.
Published: (2009-09-01) -
Preparatıon and Application of Biocompatible Carrier Implant to be Used in the Controlled Acquisition of Digoxin
by: HESNA URAL KAYALIK, et al.
Published: (2016-12-01) -
Stability of a 50 mg/mL Ceftazidime Eye-Drops Formulation
by: Gautier Eric, et al.
Published: (2018-11-01)